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Abstract
Background: Helicobacter pylori (H. pylori) has been etiologically linked with primary gastric
lymphoma (PGL) and gastric carcinoma (GC). There are a few reports of occurrence of both
diseases in the same patient with H. pylori infection.
Case presentation: We report a patient with PGL in whom the tumor regressed after surgical
resection combined with eradication of H. pylori infection. However, he developed GC on follow
up; this was temporally associated with recrudescence / re-infection of H. pylori. This is perhaps first
report of such occurrence.
Conclusions: Possible cause and effect relationship between H. pylori infection and both PGL and
GC is discussed. This case also documents a unique problem in management of PGL in tropical
countries where re-infection with H. pylori is supposed to be high.
Background
Helicobacter pylori (H. pylori) has been etiologically linked
with primary gastric lymphoma (PGL) and gastric carcino-
ma (GC) [1,2]. Evidences in favor of cause and effect rela-
tionship between H. pylori and PGL include: higher
frequency of isolation in PGL than in controls [3]; devel-
opment of the disease during long-term follow up of in-
fected subjects [4]; regression after eradication of the
organism [5]; and rapid recurrence following re-infection
[6]. Therefore, all components of Koch's postulates for es-
tablishing cause and effect relationship between H. pylori
and PGL are fulfilled [7]. Evidences in favor of etiological
relationship between H. pylori and GC are somewhat in-
complete. In most studies from developed countries H. py-
lori infection has been correlated with GC [8]; however,
the data from developing world where H. pylori infection
Published: 14 March 2002
BMC Gastroenterology 2002, 2:6
Received: 1 October 2001
Accepted: 14 March 2002
This article is available from: http://www.biomedcentral.com/1471-230X/2/6
© 2002 Ghoshal et al; licensee BioMed Central Ltd. Verbatim copying and redistribution of this article are permitted in any medium for any purpose, pro-
vided this notice is preserved along with the article's original URL.BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/6
Page 2 of 6
(page number not for citation purposes)
is more frequent and is acquired at an early age is some-
what contradictory [9,10]. There is no report of regression
of GC after eradication of H. pylori. Recently, GC has been
shown to develop in Mongolian gerbils after infection
with H. pylori[11]. However, development of GC during
follow up after fresh infection with H. pylori in humans
has not been documented despite such report in PGL [4].
Accordingly we report a patient with PGL from India in
whom surgical resection of the tumor combined with
eradication of H. pylori was followed by regression of PGL.
This patient developed metachronous GC associated with
recrudescence / re-infection of H. pylori.
Case presentation
A 32-year-old man presented in May 1998 with epigastric
pain of six months duration. The pain was constant with-
out any relation to meal or radiation to back. He also
complained of anorexia, weight loss, vomiting of copious
amount of stale food without any bile for four months.
Melena occurred once three months ago. There was no
history of fever. He denied history of gastric cancer in his
family. Physical examination revealed emaciation and
pallor. There was no lymphadenopathy, hepatosplenom-
egaly and abdominal lump. Examination of throat did not
reveal any abnormality.
Hemoglobin=85g/L, TLC=6.7 ×  109/L, ESR=78 mm/h.
Chest radiograph was normal. Abdominal ultrasonogram
did not reveal lymphadenopathy, hepatosplenomegaly or
ascites. Upper gastrointestinal (UGI) endoscopy revealed
hyperemic lower esophageal mucosa with multiple non-
confluent erosions; there was excessive food residue in-
side the lumen and multiple hypertrophied gastric folds
with erosions over these. Pyloric orifice was narrow and
endoscope could not be negotiated into the duodenum.
Six biopsies taken from the hypertrophied folds revealed
only chronic inflammatory infiltrate and no specific pa-
thology. H. pylori was not detected on histologic examina-
tion of gastric biopsies. In house rapid urease test (RUT)
was positive within 15 minutes and scanning electron mi-
croscopy (SEM, Hitachi S530, Japan) from biopsies ob-
tained from relatively normal looking areas revealed
multiple round cells (might be lymphocytes, figure 1A)
but no H. pylori. Serum titer for IgG antibody against H.
pylori using ELISA based commercially available kit
(Monobind Incorporation, California) was positive (21
IU/ml). Lansoprazole was started. With a diagnosis of gas-
tric outlet obstruction, surgery was done after 2 weeks. Af-
ter exploring the abdomen by midline incision thickening
and nodularity of antrum were detected. There was no re-
gional lymphadenopathy. Partial gastrectomy, removal of
peri-gastric lymph nodes, closure of resected end of the
duodenum in double layers and end-to-side ante-grade
retro-colic gastrojejunostomy were done. Postoperative
course was uneventful. Histological examination of re-
sected specimen revealed transmural infiltration by
mononuclear cells diffusely extending through muscularis
mucosa into the submucosa without formation of lym-
phoid follicles, cellular atypia, abnormal mitotic figures
(figure 2A) and lymphoepithelial lesions. On thorough
histologic evaluation no evidence of synchronous GC was
seen. Peri-gastric lymph nodes were not infiltrated by lym-
phoma. Bone marrow examination did not reveal any ab-
normality. On the basis of these morphological features a
diagnosis of PGL (low-grade B cell lymphoma of MALT
type by revised European-American classification) [12],
stage I E: I1 (Musshoffs modification of Ann Arbor classi-
fication) [13] and H. pylori infection were made. Patient
was treated with amoxycillin 1.5 g/d, omeprazole 40 mg/
d and tinidazole 1 g/d for two weeks to eradicate the in-
fection with H. pylori. UGI endoscopy repeated one
Figure 1
(A) Scanning electron microphotograph of gastric mucosa at
presentation showing multiple round cells (possibly lym-
phocytes) but No H. pylori (×  1000). (B) Scanning electron
microphotograph of gastric mucosa during re-infection
showing bacillus with polar flagella suggestive of H. pylori (×
8000).BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/6
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month after completion of anti-H. pylori treatment re-
vealed small sized stomach, no ulcer. RUT and Giemsa
staining of biopsies obtained from proximal stomach
were negative for H. pylori. However, a repeat UGI endos-
copy done after six months revealed a benign-looking ul-
cer (1.5 cm in diameter) at gastrojejunostomy stoma. RUT
and histology (Giemsa stain) on biopsies obtained from
proximal stomach for H. pylori were still negative. Biopsy
obtained by well technique from margin of the ulcer re-
vealed chronic inflammatory infiltrate. Flow cytometry by
standard technique [14] from these biopsies using anti-
CD 19 (B cell marker) and anti-CD3 (T cell marker) mon-
oclonal antibodies revealed polyclonal infiltrate with
6.6% CD 19 and 10.8% CD3 bearing cells (figure 3). With
a possibility of benign stomal ulcer patient was treated
with lansoprazole 30 mg/d for 3 months. After this period
of treatment, healing of the ulcer and absence of H. pylori
infection were documented by UGI endoscopy and nega-
tive RUT respectively (2 weeks after stopping lansopra-
zole). On follow up during the next six months, he
remained well with improved appetite and weight gain
(35 to 46 kg). He presented with recurrence of epigastric
pain, anorexia and vomiting in August 1999. He had lost
body weight (34 kg in August 1999). Examination re-
vealed pallor, no peripheral lymphadenopathy and ab-
dominal lump. UGI endoscopy: friable ulcerated growth
involving most of stomach with reduced distensibility of
the organ and patent gastrojejunostomy stoma. Since a
possibility of recurrent PGL was considered, flow cytome-
try was done by standard technique [14] with biopsy from
the tumor using anti-CD 19 (B cell marker) and anti-CD3
(T cell marker) antibodies; it revealed a polyclonal lym-
phocytic infiltrate consisting of 0.9% CD 19 and 3.9%
CD3 bearing cells (figure 3). Biopsies obtained from rela-
Figure 2
(A) Resected specimen of distal stomach showing diffuse infil-
tration by mononuclear cells without formation of lymphoid
follicles with obvious cellular atypia and abnormal mitotic fig-
ures (H&E ×  275). (B) The high power view of recurrent gas-
tric tumor showing pleomorphic cells, abnormal mitotic
figures, mucin secretion and formation of gland at places
diagnostic of adenocarcinoma (H&E ×  275).
Figure 3
Flow cytometry was performed using FACS calibur (Becton
Dickinson) and data were analyzed using Cell Quest pro-
gram. One parameter histogram is shown.BMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/6
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tively normal looking mucosa of stomach gave positive re-
sult to RUT. Histological examination revealed chronic
gastritis but no intestinal metaplasia. SEM (Hitachi S530,
Japan) with these biopsies revealed multiple bacilli sug-
gestive of H. pylori (figure 1B). Histopathology of biopsy
from margin of ulcers revealed multiple signet ring cells,
cellular pleomorphism, mucin secretion, abnormal mitot-
ic figures and gland formation at certain places (figure
2B). A diagnosis of GC and recrudescence / re-infection of
H. pylori were made. Patient denied further treatment at
this stage and left the hospital.
Discussion and conclusion
High index of suspicion is required for early diagnosis of
PGL in developing countries. Endoscopic features of PGL
may be very non-specific. Endoscopic findings like slight
increase in thickness of gastric folds, multiple benign
looking gastric ulcers or erosions [15] are too non-specific
to suspect the disease unless endoscopist specifically
looks for it. Endoscopic mucosal biopsy may miss the di-
agnosis [16] and may show only benign looking lym-
phocytic infiltrate as in the present case. Molecular
diagnostic methods essential for confirming the diagnosis
are not widely available in developing countries including
ours. Early diagnosis is important, as eradication of H. py-
lori has been commonly shown to cause regression in an
early stage of the disease [17]. H. pylori has been found
more often in patients with PGL [3], chronic H. pylori in-
fection progresses from polyclonal lymphocytic prolifera-
tion to PGL [4], and its eradication leads to regression [5].
Recurrence of PGL following re-infection with H. pylori
following eradication has been documented in the litera-
ture [6]. Presence of H. pylori infection in our patient at
presentation was evidenced by positive RUT (sensitivity
92%, specificity 80%) [18] and serology; absence of or-
ganism in SEM might be due to sampling error as similar
phenomenon has been reported earlier in presence of gas-
tric atrophy and intestinal metaplasia, both being com-
mon in chronic gastritis and malignancy [19]. Though,
biopsy was obtained from endoscopically normal-looking
mucosa, SEM showed round cell infiltration suggesting
involvement by lymphoma. Absence of H. pylori in that
area is quite expected. Diagnosis of PGL in our patient
could be further confirmed by molecular biological meth-
ods before eradication of H. pylori. However, typical his-
tology picture is quite diagnostic of PGL [20]. We could
demonstrate clinical and histologic regression of the dis-
ease following surgical resection followed by eradication
of H. pylori (documented by negative RUT and histology
obtained from unresected proximal stomach). Flow cy-
tometry of gastric mucosal biopsy documented polyclonal
lymphocytic infiltrate confirming absence of residual lym-
phoma. Molecular evidences of the neoplasm may persist
after treatment despite histological regression [21]. How-
ever, eradication of H. pylori removes growth stimulus for
PGL. Histological and molecular relapse in absence of re-
infection with H. pylori are rare and transient [22].
Our patient developed GC on follow up after regression of
PGL. This was temporally associated with re-infection
with H. pylori. Positive RUT and demonstration of typical
bacilli in SEM documented re-infection. Since we could
not demonstrate a different genotype of H. pylori at the
time of re-infection a possibility of recrudescence of earli-
er infection can not be entirely excluded though seems
less likely. Development of intestinal metaplasia, a pre-
cursor of GC [23] and advanced cancer [11] has been re-
ported after infection with H. pylori in Mongolian gerbils
recently. This is perhaps the first report of development of
GC following recrudescence / re-infection with H. pylori in
human. We can not rule out a possibility of spontaneous
development of GC. However, this seems less likely as in
most cases of combined tumor reported earlier GC and
PGL were synchronous in nature [24–29]. In a single se-
ries of 12 cases two developed metachronous tumor in
both of whom GC preceded PGL [24]. In contrast, devel-
opment of GC is expected to occur later in the course of H.
pylori infection in patients with PGL [30]. The latter devel-
ops in the active phase of inflammation whereas the
former in the pre-atrophic stage of gastritis [30]. In our pa-
tient resected specimen of PGL on thorough histologic ex-
amination did not reveal presence of synchronous GC.
Therefore, as expected, GC in our patient developed later
and was temporally associated with recrudescence / re-in-
fection with H. pylori. Occurrence of metachronous GC af-
ter regression of PGL with eradication of H. pylori has been
reported rarely [31,32]. Four cases of metachronous GC
after regression of PGL with H. pylori eradication have
been reported till date [31,32]. Development of GC in our
patient was temporally associated with re-infection with
H. pylori following regression of PGL. This is perhaps the
first report of such an association. Considering several ear-
lier studies [33,34], which suggested reduction in risk of
GC following H. pylori eradication, temporal association
of development of GC with recrudescence / re-infection
with H. pylori in our patient is not difficult to explain.
However, development of GC within a short period of
time after fresh infection with H. pylori is somewhat odd
as GC takes time to develop after infection with H. py-
lori[35]. A possibility of genetic or immunological predis-
position can not be excluded. Further, since the patient
was already chronically infected with H. pylori he might
have been predisposed. Some workers have suggested a
possibility of immunological containment of dysplastic
epithelial cells by lymphocytic infiltrate [36]. Whether im-
munological imbalance resulting from regression of lym-
phocytic infiltrate could contribute to rapid development
of GC, which got further triggered by re-infection or recru-
descence of pre-existing infection with H. pylori remains
an open question. Development of GC in this patientBMC Gastroenterology 2002, 2 http://www.biomedcentral.com/1471-230X/2/6
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might be related to changes induced by many years of H.
pylori related gastritis rather than a few months of re-infec-
tion. However, since there was a temporal relation with re-
infection, it could also be related to progression of exist-
ing changes induced over many years by re-infection. This
remains a conjecture.
In conclusion, we have shown regression of PGL after sur-
gical resection combined with eradication of H. pylori and
development of GC in association with reinfection with
H. pylori in the present case. This may suggest the possibil-
ity of cause and effect relationship of both these malig-
nancies to H. pylori. This case also highlights a unique
problem in management of PGL in tropical countries
where re-infection with H. pylori is supposed to be high
[37].
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